Effects of insulin sensitivity, body composition, and fitness on lipoprotein particle sizes and concentrations determined by nuclear magnetic resonance

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 4, 2011, Pages

  Irving, Brian A ^a   Nair, K Sreekumaran ^a   Srinivasan, Manivannan ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY COMPOSITION; CARDIOPULMONARY HEMODYNAMICS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FITNESS; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID ANALYSIS; LIPID COMPOSITION; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE; OBESITY; PARTICLE SIZE; PRIORITY JOURNAL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY COMPOSITION; FEMALE; HUMANS; INSULIN RESISTANCE; LIPOPROTEINS; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OSMOLAR CONCENTRATION; PARTICLE SIZE; PHYSICAL FITNESS; YOUNG ADULT;

EID: 79953883575     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-2170     Document Type: Article

References (20)

1. ReavenGM1988 Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37:1595-1607 (Pubitemid 19004941)
2. Rizzo M, Pernice V, Frasheri A, Berneis K 2008 Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease. Atherosclerosis 197:237-241 (Pubitemid 351273244)
3. Arsenault BJ, Lemieux I, Després JP, Gagnon P,WarehamNJ, Stroes ES, Kastelein JJ, Khaw KT, Boekholdt SM 2009 HDL particle size and the risk of coronary heart disease in apparently healthy men and women: The EPIC-Norfolk prospective population study. Atherosclerosis 206:276-281
4. Austin MA, King MC, Vranizan KM, KraussRM1990 Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82:495-506 (Pubitemid 20257828)
5. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després JP 1997 Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 95:69-75 (Pubitemid 27029945)
6. Rosenson RS, Otvos JD, FreedmanDS2002 Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the Pravastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am J Cardiol 90: 89-94 (Pubitemid 34775113)
7. Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y 2003 Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance. Diabetes 52:453-462 (Pubitemid 36173203)
8. Lee S, Kuk JL, Katzmarzyk PT, Blair SN, Church TS, Ross R 2005 Cardiorespiratory fitness attenuates metabolic risk independent of abdominal subcutaneous and visceral fat in men. Diabetes Care 28: 895-901 (Pubitemid 40434492)
9. Hassinen M, Lakka TA, Savonen K, Litmanen H, Kiviaho L, Laaksonen DE, Komulainen P, Rauramaa R 2008 Cardiorespiratory fitness as a feature of metabolic syndrome in older men and women: The Dose-Responses to Exercise Training study (DR's EXTRA). Diabetes Care 31:1242-1247
10. Pascot A, Lemieux I, Prud'homme D, Tremblay A, Nadeau A, Couil-lard C, Bergeron J, Lamarche B, Després JP 2001 Reduced HDL particle size as an additional feature of the atherogenic dyslipidemia of abdominal obesity. J Lipid Res 42:2007-2014 (Pubitemid 34001049)
11. Karakelides H, Irving BA, Short KR, O'Brien P, Nair KS 2010 Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes 59:89-97
12. Lanza IR, Short DK, Short KR, Raghavakaimal S, Basu R, Joyner MJ, McConnell JP, Nair KS 2008 Endurance exercise as a countermeasure for aging. Diabetes 57:2933-2942
13. Jeyarajah EJ, Cromwell WC, Otvos JD 2006 Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 26:847-870 (Pubitemid 44716510)
14. Selby JV, Austin MA, Newman B, Zhang D, Quesenberry Jr. CP, Mayer EJ, Krauss RM 1993 LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 88:381-387 (Pubitemid 23228036)
15. Reaven GM, Chen YD, Jeppesen J, Maheux P, Krauss RM 1993 Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 92:141-146 (Pubitemid 23208989)
16. Rainwater DL, Mitchell BD, Comuzzie AG, Haffner SM 1999 Relationship of low-density lipoprotein particle size and measures of adiposity. Int J Obes Relat Metab Disord 23:180-189 (Pubitemid 29057514)
17. Katzmarzyk PT, Church TS, Blair SN 2004 Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men. Arch Intern Med 164: 1092-1097 (Pubitemid 38668988)
18. Brock DW, Irving BA, Gower B, Hunter GR 20 July 2010 Differences emerge in visceral adipose tissue accumulation after selection for innate cardiovascular fitness. Int J Obes (Lond) 10.1038/ ijo.2010.133
19. Berneis KK, Krauss RM 2002 Metabolic origins and clinical significance of LDL heterogeneity. J Lipid Res 43:1363-1379
20. Barzilai N, Atzmon G, Schechter C, Schaefer EJ, Cupples AL, Lipton R, Cheng S, Shuldiner AR 2003 Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA 290: 2030-2040 (Pubitemid 37430586)